Revitalize your skin with non-ablative laser energy to correct initial signs of sun damage, pigmentation, uneven skin tone, texture & aging
First, we lack large-scale, long-term studies proving its beneficial effects on humans
Mar 19, 2026, 12:04 ET Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment * with Wegovy HD (~19% regardless of whether patients stayed on treatment ** ) in the STEP UP trial 1 In the STEP UP trial, about one in three trial participants taking Wegovy HD achieved 25% weight loss or higher 1 This approval for Wegovy further expands its already robust label inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines PLAINSBORO, N.J., March 19, 2026 /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of Wegovy , Wegovy HD (semaglutide) injection 7.2 mg, which demonstrated substantial weight loss in adults with obesity in the STEP UP trial
If eligible, your custom prescription ships directly to you, typically within a week, in temperature-controlled packaging with everything you need
"I'm young and I'd rather not be on this medication for a long time
Key Experimental Conditions These conditions were optimized to achieve efficient digestion while minimizing unwanted reactions